Bellicum Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Bellicum Pharmaceuticals has a total shareholder equity of $4.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.9M and $2.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$5.91m |
| Equity | US$4.60m |
| Total liabilities | US$2.25m |
| Total assets | US$6.85m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: BLCM's short term assets ($6.8M) exceed its short term liabilities ($2.2M).
Long Term Liabilities: BLCM has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BLCM is debt free.
Reducing Debt: BLCM has no debt compared to 5 years ago when its debt to equity ratio was 38.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BLCM has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BLCM has less than a year of cash runway if free cash flow continues to grow at historical rates of 23.6% each year.